BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Virol. Dec 25, 2025; 14(4): 115626
Published online Dec 25, 2025. doi: 10.5501/wjv.v14.i4.115626
Table 1 Comparison between patients requiring antiviral therapy and those with spontaneous clearance, median (interquartile ranges)
Variable
Treated (n = 6)
Not treated (n = 11)
P value (Mann-Whitney U/Fisher exact)
Age (years)45 (33, 61)39 (23, 60)0.309
Sex (male/female)4/26/50.205
Initial VL (IU/mL)1631 (612, 50200)690 (150, 1990)0.015
Peak VL (IU/mL)30150 (812, 641000)1320 (150, 18000)0.007
Time to reactivation (days)24 (9, 29)25 (5, 38)0.66
Time to neutrophil engraftment (days)11 (10, 12)12 (10, 19)0.884